Lithium treatment enhances estradiol-induced proliferation and hyperplasia formation in the uterus of mice

Andrei G Gunin, А. Г. Гунин, Vladimir U. Emelianov, Igor U Mironkin, I. U. Mironkin, Mikhail P Morozov, M. P. Morozov, Alexei S. Tolmachev
European Journal of Obstetrics & Gynecology and Reproductive Biology · 2004 · vol. 114(1) , pp. 83–91 · doi:10.1016/j.ejogrb.2003.09.023 · PMID:15099877 · W2080055110
Lab / animal OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-31 ⓘ

Lithium treatment increased estradiol-induced uterine proliferation and hyperplasia in mice, associated with decreased uterine expression of estrogen receptors, beta-catenin, and glycogen synthase kinase-3beta.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVES: It is suggested that the Wnt/beta-catenin pathway plays a role in the regulation of estrogen action in the uterus. However, this suggestion has not been proved. Lithium can mimic increased activity of the Wnt/beta-catenin pathway by blocking the activity of glycogen synthase kinase-3beta. There are no data on the effects of lithium on estrogen-dependent processes in the uterus. This work was therefore aimed to examine the action of lithium on proliferative and morphogenetic reactions in the uterus under short- and long-term estrogen treatments. STUDY DESIGN: Ovariectomized mice received estradiol dipropionate (2 microg per 100g; s.c.) once a week or vehicle and drank tap water with 0.05% lithium chloride or plain tap water for 2 or 30 days. RESULTS: In animals treated with estradiol and lithium for a month, the incidence of atypical endometrial hyperplasia was significantly higher. In animals treated with estradiol and lithium for 2 days or for a month, uterine mass, the number of mitotic cells and BrdU-labelled cells in luminal epithelium, glandular epithelium, stromal and myometrial cells was markedly greater, whereas the levels of estrogen receptors-alpha, beta-catenin and glycogen synthase kinase-3beta were markedly lower in all uterine compartments, than in those in mice received estradiol with no lithium to drink. CONCLUSIONS: Lithium treatment results in an increase in estradiol-induced proliferative and morphogenetic changes in the uterus. This action of lithium is associated with decreased expression of estrogen receptors-alpha, beta-catenin and glycogen synthase kinase-3beta in the uterus.

My notes (saved in your browser only)

MeSH descriptors

Endometrial Hyperplasia Estradiol Lithium Chloride Uterus Administration, Oral Animals beta Catenin Cytoskeletal Proteins Cytoskeletal Proteins Disease Models, Animal Endometrial Hyperplasia Estradiol Estradiol Female Glycogen Synthase Kinase 3 Glycogen Synthase Kinase 3 Glycogen Synthase Kinase 3 beta Injections, Subcutaneous Lithium Chloride Lithium Chloride

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (36)

Cited by (5)

Source provenance

openalex
last seen: 2026-05-11T06:37:04.871248+00:00
pubmed
last seen: 2026-10-08T21:02:29.018211+00:00
License: CC0 · commercial use OK